Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serine/threonine-protein kinase SIK2 is a member of the AMP-activated protein kinase (AMPK) family and plays a pivotal role in regulating fatty acid oxidation, autophagy, immune response, glucose metabolism, and insulin signaling. It modulates the activity of transcription factors and is involved in T-cell development. SIK2 also plays a role in regulating glucose metabolism through control of the CRTC2-CREB function in white adipocytes and represses AKT/GSK3β/β-catenin signaling in gastric cancer. Due to its involvement in metabolic regulation and cancer-related pathways, SIK2 is a potential therapeutic target for metabolic disorders and certain cancers.
Inhibition of SIK2 activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine/threonine-protein kinase SIK2 (SIK2).